RecruitingNCT06424327

A Registry for People With Lung Cancer

Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

600 participants

Start Date

May 15, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Cancer Lung Cancer Stage I

Summary

Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study that collects information from people being evaluated or treated for early-stage lung cancer. The goal is to track long-term outcomes and improve understanding of how different surgical approaches affect survival and quality of life. **You may be eligible if...** - You are 18 or older - You have suspected or confirmed early-stage non-small cell lung cancer (Stage I) - You have not previously had lung cancer or received cancer treatment in the past 5 years **You may NOT be eligible if...** - You are currently receiving lung cancer treatment - You have had chemotherapy or radiation for a prior lung cancer - You have another active cancer - You have a carcinoid tumor - You have had another type of cancer in the past 3 years (with some exceptions) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient-Reported Outcomes Measurement Information System

Participants-reported outcomes will be collected using the Patient-Reported Outcomes Measurement Information System (PROMIS). PROMIS is a web-based platform developed by the National Institutes of Health. Scoring is standardized on a scale from 0 to 100, with a population mean of 50 and standard deviation of 10 units. High scores mean more of the concept being measured. This study will use PROMIS surveys assessing three domains: physical function (PROMIS bank version 2.0), pain interference (PROMIS bank version 1.1), and dyspnea severity (PROMIS bank version 1.0)

Locations(15)

Rush University Medical Center (Data collection only)

Chicago, Illinois, United States

Endeavor Health

Evanston, Illinois, United States

University of Michigan (Data Collection Only)

Ann Arbor, Michigan, United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)

Commack, New York, United States

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, New York, United States

Thomas Jefferson University Hospital (Data Collection Only)

Philadelphia, Pennsylvania, United States

ALLEGHENY HEALTH NETWORK (Data Collection Only)

Pittsburgh, Pennsylvania, United States

MD Anderson Cancer Center (Data Collection Only)

Houston, Texas, United States

University Health Network (Data Collection Only)

Toronto, Ontario, Canada

Centre Hospitalier de l'Université de Montreal (Data Collection Only)

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06424327

Related Trials

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

NCT024217181 location

Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules

NCT053069121 location

Metabolic Biomarkers in Thoracic Cancers

NCT020958081 location

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT060606139 locations

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

NCT070589483 locations